T2 Biosystems Owners | StatInvestor

Health Care & Life Sciences » Medical Equipment & Supplies | T2 Biosystems Inc.

T2 Biosystems Inc. | Ownership

Companies that own T2 Biosystems Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Goldman Sachs & Co. LLC (Private Banking)

4,186,456

9.57%

0.01%

06/30/2018

Senvest Management LLC

2,664,131

6.09%

-28,472

1.11%

06/30/2018

BlackRock Fund Advisors

1,698,928

3.88%

1,542,335

06/30/2018

The Vanguard Group, Inc.

1,441,058

3.29%

489,501

06/30/2018

Millennium Management LLC

1,176,522

2.69%

890,097

0.01%

06/30/2018

Tiger Management LLC

1,006,175

2.29%

-1,011,397

1.55%

06/30/2018

Lagoda Investment Management LP

954,881

2.18%

-827,883

1.89%

06/30/2018

Renaissance Technologies LLC

821,500

1.88%

651,300

0.01%

06/30/2018

Ardsley Advisory Partners

755,000

1.73%

755,000

0.77%

06/30/2018

Morgan Stanley Smith Barney LLC (Private Banking)

719,072

1.64%

262,650

06/30/2018

About T2 Biosystems

View Profile

Address	101 Hartwell Avenue Lexington Massachusetts 02421 United States
Employees	-
Website	http://www.t2biosystems.com
Updated	07/08/2019
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection including one colony forming unit per milliliter. The company was founded by Michael J.